|
Volumn 13, Issue 10, 2002, Pages 1143-1149
|
Regulatory issues for clinical gene therapy trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOSAFETY;
BIOTECHNOLOGY;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DRUG MONITORING;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
GOVERNMENT;
HUMAN;
INFORMED CONSENT;
PRACTICE GUIDELINE;
REVIEW;
RISK BENEFIT ANALYSIS;
BIOETHICS AND PROFESSIONAL ETHICS;
ETHICS;
GENETICS AND REPRODUCTION;
HEALTH CARE ORGANIZATION;
LEGAL APPROACH;
LEGAL ASPECT;
PROFESSIONAL STANDARD;
UNITED STATES;
CLINICAL TRIALS;
ETHICS COMMITTEES, RESEARCH;
GENE THERAPY;
HUMAN;
INFORMED CONSENT;
NATIONAL INSTITUTES OF HEALTH (U.S.);
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
HUMANS;
BIOETHICS AND PROFESSIONAL ETHICS;
GENETICS AND REPRODUCTION;
LEGAL APPROACH;
|
EID: 0036019187
PISSN: 10430342
EISSN: None
Source Type: Journal
DOI: 10.1089/104303402320138925 Document Type: Review |
Times cited : (24)
|
References (0)
|